Medical Xpress November 19, 2024
A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of Clinical Investigation has revealed a connection between COVID-19 infection and cancer regression. The team’s discovery could pave the way for novel cancer treatments.
In an unexpected twist, the scientists observed that the RNA from the SARS-CoV-2 virus—responsible for COVID-19—triggered the development of a unique type of immune cell with anti-cancer properties. These cells, dubbed “inducible nonclassical monocytes (I-NCMs),” were found to attack cancer cells and could potentially be harnessed to treat cancers that are resistant to current therapies.
These findings possibly explain the mechanism behind the reported regression of certain cancers following COVID-19 infection.
“This discovery opens up a new avenue...
Today's Sponsors
Today's Sponsor